Swiss stocks – Factors to watch on March 31

ZURICH, March 31 (Reuters) – Swiss shares are set to tick up
on Thursday in line with other European markets after U.S.
labour data suggested the economic recovery is on track.

The Swiss blue-chip index SMI(.SSMI: Quote, Profile, Research) was indicated to open 8
points higher at 6,408 points, premarket data provided by bank
Clariden Leu showed.(CLPRE: Quote, Profile, Research)

The following are some of the main factors expected to
affect Swiss stocks on Thursday.

ZURICH FINANCIAL (ZURN.VX: Quote, Profile, Research)

Claims against Swiss insurer Zurich Financial (ZURN.VX: Quote, Profile, Research) from
the five natural disasters to hit the Asia-Pacific region so far
in 2011 could be around $500 million, the insurer said.

For related news, click on [ZURN.VX]

UBS (UBSN.VX: Quote, Profile, Research)

Swiss bank UBS AG, the leader in equity underwriting in Asia
Pacific, plans to double its China staff in three to four years
as it expands stock research coverage to small and medium
companies in China, the bank’s co-chief executive for the region
said.

For related news, click on [UBSN.VX]

ZURICH FINANCIAL (ZURN.VX: Quote, Profile, Research)

Holds annual general meeting

For related news click on [ZURN.VX]

CLARIANT (CLN.VX: Quote, Profile, Research)

Annual general meeting

For related news click on [CLN.VX]

ECONOMY [M-CH]

COMPANY STATEMENTS [CNR-CH]

* Julius Baer (BAER.VX: Quote, Profile, Research) says Bernhard Hodler new Chief
Operating Officer of Bank Julius Baer [BAER.VX]

* Cytos (CYTN.S: Quote, Profile, Research) says United States Army and Cytos
Biotechnology Collaborate on Malaria Vaccines Research [CYTN.S]

* Addex (ADXN.S: Quote, Profile, Research) Initiates Phase IIa Clinical Trial of
Dipraglurant-IR in Parkinson’s Disease Levodopa-Induced Dyskines
[ADXN.S]

* Adecco (ADEN.VX: Quote, Profile, Research) Group announces tender and exchange
offers for existing debt securities [ADEN.VX]

* Gurit acquires balsa material producer Balseurop (GUR.S: Quote, Profile, Research)

* Kardex (KARN.S: Quote, Profile, Research) reports an acquisition-related 3.8 percent
increase in net revenues to 355.9 million euro and an operating
loss of 6.4 million euro, net loss of 9.8 million euro[KARN.S]

* Comet (COTN.S: Quote, Profile, Research) says Thomas Hinderling to step down from
Board of Directors at next annual meeting [COTN.S]

* Newron (NWRN.S: Quote, Profile, Research) says to Broaden Collaboration on New
Therapies for Central Nervous System Diseases with Merck
Serono(MRCG.DE: Quote, Profile, Research) [NWRN.S][MRCG.DE]

EQUITY RESEARCH [CH-RCH]

For companies trading ex-dividend, please click on:

(.EX.S: Quote, Profile, Research) for all Swiss stocks

(.EXSMI.S: Quote, Profile, Research) for blue chips

(.EXNSMI.S: Quote, Profile, Research) for other stocks

Swiss stocks – Factors to watch on March 31